Kiai Parsa bought 661 shares of MEDIFAST INC at $13.03 for $8.61k on Nov 4, 2026

Buy
Form 4 code P. Open-market or private purchase of a non-derivative or derivative security.
Director
DIR
Filed Nov 6, 2026

Facts from the filing

Form 4 · Non-derivative, table I
Disclosed value
$8,609.86Shares × reported price
Shares traded
661Common Stock
Price per share
$13.03Reported price. Read footnotes for ranges.
% of reported position traded
3.24%This security and ownership context
Holdings after
21,089Indirect · Notes
Trade date
Nov 4, 2026Buy
Filed
Nov 6, 2026, 2:28 PM ET2-day reporting delay
Accession
0001213900-26-116801Code P · Transaction 394484
How reported position traded is calculated

Shares purchased ÷ (holdings after − shares purchased). Estimated position before: 20,428 shares.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

Other trades in this filing

No other transaction rows in this filing.

1 transaction row in this filing. Joint filers share the same rows.

MED price since this filing

Daily closing prices, with the filing date and available return windows. Return methodology
MED · Daily closing priceDaily price data is pending. The chart appears when valid daily closes are available.
Filing dateReturn windows appear as prices become available.
Pre-filing1mo ago −8.9%1w ago −4.1%1d ago −1.7%
Returns since7d +0.4%30d90d180d1y

Footnotes in full

F1: Ownership of Steamboat Capital Partners II, LP (II). F2: Steamboat Capital Partners GP, LLC (GP) is general partner of, and entitled to receive a performance allocation from II. Parsa Kiai ("Kiai") is the Managing Member of GP. Accordingly, Kiai may be deemed to have a pecuniary interest in the shares owned by II. Kiai disclaims beneficial ownership of securities reported hereon except to the extent of his pecuniary interest therein. F3: This is an average price. Actual prices paid for the shares purchased on 11/04/26 and reported on this line range from $12.87 to $13.15. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.